Global Oncology Nutrition 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR112403304

Publication Date:

November 28, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Oncology Nutrition market size was valued at USD 2172 million in 2023 and is forecast to a readjusted size of USD 3778.4 million by 2030 with a CAGR of 8.2% during review period.
Cancers are among the leading causes of morbidity and mortality worldwide, and the number of new cases is expected to rise significantly over the next decades.
Nutritional oncology is an increasingly active interdisciplinary field where cancer is investigated as both a systemic and local disease originating with the changes in the genome and progressing through a multi-step process which may be influenced at many points in its natural history by nutritional factors that could impact the prevention of cancer, the quality of life of cancer patients, and the risk of cancer recurrence in the rapidly increasing population of cancer survivors.
The report includes an overview of the development of the Oncology Nutrition industry chain, the market status of Clinic (Head and Neck Cancers, Stomach and Gastrointestinal Cancers), Hospitals (Head and Neck Cancers, Stomach and Gastrointestinal Cancers), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncology Nutrition.
Regionally, the report analyzes the Oncology Nutrition markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncology Nutrition market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oncology Nutrition market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncology Nutrition industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Head and Neck Cancers, Stomach and Gastrointestinal Cancers).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncology Nutrition market.
Regional Analysis: The report involves examining the Oncology Nutrition market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncology Nutrition market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oncology Nutrition:
Company Analysis: Report covers individual Oncology Nutrition players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncology Nutrition This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinic, Hospitals).
Technology Analysis: Report covers specific technologies relevant to Oncology Nutrition. It assesses the current state, advancements, and potential future developments in Oncology Nutrition areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncology Nutrition market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Oncology Nutrition market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Head and Neck Cancers
Stomach and Gastrointestinal Cancers
Liver Cancer
Pancreatic Cancer
Esophageal Cancer
Lung Cancer
Breast Cancer
Blood Cancer
Other Cancers
麻豆原创 segment by Application
Clinic
Hospitals
Others
麻豆原创 segment by players, this report covers
Abbott Laboratories
Nestle
Danone
Fresenius Kabi
B. Braun
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oncology Nutrition product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oncology Nutrition, with revenue, gross margin and global market share of Oncology Nutrition from 2019 to 2024.
Chapter 3, the Oncology Nutrition competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oncology Nutrition market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oncology Nutrition.
Chapter 13, to describe Oncology Nutrition research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Oncology Nutrition
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Oncology Nutrition by Type
1.3.1 Overview: Global Oncology Nutrition 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Oncology Nutrition Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Head and Neck Cancers
1.3.4 Stomach and Gastrointestinal Cancers
1.3.5 Liver Cancer
1.3.6 Pancreatic Cancer
1.3.7 Esophageal Cancer
1.3.8 Lung Cancer
1.3.9 Breast Cancer
1.3.10 Blood Cancer
1.3.11 Other Cancers
1.4 Global Oncology Nutrition 麻豆原创 by Application
1.4.1 Overview: Global Oncology Nutrition 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinic
1.4.3 Hospitals
1.4.4 Others
1.5 Global Oncology Nutrition 麻豆原创 Size & Forecast
1.6 Global Oncology Nutrition 麻豆原创 Size and Forecast by Region
1.6.1 Global Oncology Nutrition 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Oncology Nutrition 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Oncology Nutrition 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Oncology Nutrition 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Oncology Nutrition 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Oncology Nutrition 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Oncology Nutrition 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Oncology Nutrition Product and Solutions
2.1.4 Abbott Laboratories Oncology Nutrition Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Nestle
2.2.1 Nestle Details
2.2.2 Nestle Major Business
2.2.3 Nestle Oncology Nutrition Product and Solutions
2.2.4 Nestle Oncology Nutrition Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Nestle Recent Developments and Future Plans
2.3 Danone
2.3.1 Danone Details
2.3.2 Danone Major Business
2.3.3 Danone Oncology Nutrition Product and Solutions
2.3.4 Danone Oncology Nutrition Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Danone Recent Developments and Future Plans
2.4 Fresenius Kabi
2.4.1 Fresenius Kabi Details
2.4.2 Fresenius Kabi Major Business
2.4.3 Fresenius Kabi Oncology Nutrition Product and Solutions
2.4.4 Fresenius Kabi Oncology Nutrition Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Fresenius Kabi Recent Developments and Future Plans
2.5 B. Braun
2.5.1 B. Braun Details
2.5.2 B. Braun Major Business
2.5.3 B. Braun Oncology Nutrition Product and Solutions
2.5.4 B. Braun Oncology Nutrition Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 B. Braun Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Oncology Nutrition Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Oncology Nutrition by Company Revenue
3.2.2 Top 3 Oncology Nutrition Players 麻豆原创 Share in 2023
3.2.3 Top 6 Oncology Nutrition Players 麻豆原创 Share in 2023
3.3 Oncology Nutrition 麻豆原创: Overall Company Footprint Analysis
3.3.1 Oncology Nutrition 麻豆原创: Region Footprint
3.3.2 Oncology Nutrition 麻豆原创: Company Product Type Footprint
3.3.3 Oncology Nutrition 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Oncology Nutrition Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Oncology Nutrition 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Oncology Nutrition Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Oncology Nutrition 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Oncology Nutrition Consumption Value by Type (2019-2030)
6.2 North America Oncology Nutrition Consumption Value by Application (2019-2030)
6.3 North America Oncology Nutrition 麻豆原创 Size by Country
6.3.1 North America Oncology Nutrition Consumption Value by Country (2019-2030)
6.3.2 United States Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Oncology Nutrition Consumption Value by Type (2019-2030)
7.2 Europe Oncology Nutrition Consumption Value by Application (2019-2030)
7.3 Europe Oncology Nutrition 麻豆原创 Size by Country
7.3.1 Europe Oncology Nutrition Consumption Value by Country (2019-2030)
7.3.2 Germany Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Oncology Nutrition Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Oncology Nutrition Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Oncology Nutrition 麻豆原创 Size by Region
8.3.1 Asia-Pacific Oncology Nutrition Consumption Value by Region (2019-2030)
8.3.2 China Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Oncology Nutrition Consumption Value by Type (2019-2030)
9.2 South America Oncology Nutrition Consumption Value by Application (2019-2030)
9.3 South America Oncology Nutrition 麻豆原创 Size by Country
9.3.1 South America Oncology Nutrition Consumption Value by Country (2019-2030)
9.3.2 Brazil Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Oncology Nutrition Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Oncology Nutrition Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Oncology Nutrition 麻豆原创 Size by Country
10.3.1 Middle East & Africa Oncology Nutrition Consumption Value by Country (2019-2030)
10.3.2 Turkey Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Oncology Nutrition 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Oncology Nutrition 麻豆原创 Drivers
11.2 Oncology Nutrition 麻豆原创 Restraints
11.3 Oncology Nutrition Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Oncology Nutrition Industry Chain
12.2 Oncology Nutrition Upstream Analysis
12.3 Oncology Nutrition Midstream Analysis
12.4 Oncology Nutrition Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Abbott Laboratories
Nestle
Danone
Fresenius Kabi
B. Braun

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.